These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7850755)

  • 41. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults.
    Gemmati D; Ongaro A; Scapoli GL; Della Porta M; Tognazzo S; Serino ML; Di Bona E; Rodeghiero F; Gilli G; Reverberi R; Caruso A; Pasello M; Pellati A; De Mattei M
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):787-94. PubMed ID: 15159311
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular biologic studies in the clinical evaluation of non-Hodgkin's lymphoma.
    Hardy R; Horning SJ
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):891-900. PubMed ID: 1938760
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distribution of ABO blood groups in acute leukaemias and lymphomas.
    Vadivelu MK; Damodaran S; Solomon J; Rajaseharan A
    Ann Hematol; 2004 Sep; 83(9):584-7. PubMed ID: 15175895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA repair gene polymorphisms in B cell non-Hodgkin's lymphoma.
    Bahceci A; Paydas S; Tanriverdi K; Ergin M; Seydaoglu G; Ucar G
    Tumour Biol; 2015 Mar; 36(3):2155-61. PubMed ID: 25400036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular biology of non-Hodgkin's lymphomas.
    McKeithan TW
    Semin Oncol; 1990 Feb; 17(1):30-42. PubMed ID: 2406916
    [No Abstract]   [Full Text] [Related]  

  • 46. TGF-beta1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients.
    Mazur G; Bogunia-Kubik K; Wrobel T; Kuliczkowski K; Lange A
    Cytokine; 2006 Feb; 33(3):145-9. PubMed ID: 16524740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Restriction fragment length polymorphisms in the ETS-1 proto-oncogene. Comparison of Saudi and Western populations.
    Parkar MH; Seid JM; Rowson JM; Stringer BM; Vencer LJ; Aur RJ; Goyns MH
    Experientia; 1988 Dec; 44(11-12):1019-20. PubMed ID: 2461869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical, morphologic, immunophenotypic, and molecular genetic analysis of bilateral ocular adnexal lymphoid neoplasms in 17 patients.
    McNally L; Jakobiec FA; Knowles DM
    Am J Ophthalmol; 1987 Apr; 103(4):555-68. PubMed ID: 3494404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy.
    Timuragaoglu A; Dizlek S; Uysalgil N; Tosun O; Yamac K
    Ann Hematol; 2006 Dec; 85(12):863-8. PubMed ID: 16944145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Epidemiology studies on associations between gene polymorphisms and non-Hodgkin's lymphoma].
    Ye XB; Fu H
    Wei Sheng Yan Jiu; 2006 May; 35(3):384-6. PubMed ID: 16921776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restriction fragment length polymorphisms of L-myc and myb in human leukaemia and lymphoma in relation to age-selected controls.
    Chenevix-Trench G; Southall M; Kidson C
    Br J Cancer; 1989 Dec; 60(6):872-4. PubMed ID: 2574989
    [No Abstract]   [Full Text] [Related]  

  • 52. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
    Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis].
    Yi B; Pei Y; Wang C; Jiang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1099-104. PubMed ID: 27412943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel MspI PCR-RFLP in the human cytosine 5-methyltransferase gene: lack of relevance for malignant lymphoproliferative disease and breast cancer.
    Bagwe AN; Ahmed MO; Franchina M; Spagnolo DV; Papadimitriou JM; Kay PH
    Hum Hered; 1998; 48(4):226-9. PubMed ID: 9694254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: a population-based case-control study.
    Chiu BC; Kolar C; Gapstur SM; Lawson T; Anderson JR; Weisenburger DD
    Br J Haematol; 2005 Mar; 128(5):610-5. PubMed ID: 15725081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of a vitamin D receptor gene polymorphism with localized early-onset periodontal diseases.
    Hennig BJ; Parkhill JM; Chapple IL; Heasman PA; Taylor JJ
    J Periodontol; 1999 Sep; 70(9):1032-8. PubMed ID: 10505806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glutathione S-transferase P1 genotype and prognosis in Hodgkin's lymphoma.
    Hohaus S; Di Ruscio A; Di Febo A; Massini G; D'Alo' F; Guidi F; Mansueto G; Voso MT; Leone G
    Clin Cancer Res; 2005 Mar; 11(6):2175-9. PubMed ID: 15788664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methylenetetrahydrofolate reductase gene polymorphisms (677C > T and 1298A > C) in Egyptian patients with non-Hodgkin lymphoma.
    Nasr AS; Sami RM; Ibrahim NY
    J Cancer Res Ther; 2012; 8(3):355-60. PubMed ID: 23174714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymorphism of the human c-abl gene: relation to incidence and course of chronic myelogenous leukemia.
    Daniel L; Ahmed CM; Bloodgood RS; Kidd JR; Castiglione CM; Duttagupta S; Lebowitz P
    Oncogene; 1987 May; 1(2):193-200. PubMed ID: 2894000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.